These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9568181)

  • 21. Impact of mistletoe lectin binding in breast cancer.
    Fritz P; Dippon J; Kierschke T; Siegle I; Möhring A; Moisa A; Mürdter TE
    Anticancer Res; 2004; 24(2C):1187-92. PubMed ID: 15154645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystal structure of mistletoe lectin I from Viscum album.
    Krauspenhaar R; Eschenburg S; Perbandt M; Kornilov V; Konareva N; Mikailova I; Stoeva S; Wacker R; Maier T; Singh T; Mikhailov A; Voelter W; Betzel C
    Biochem Biophys Res Commun; 1999 Apr; 257(2):418-24. PubMed ID: 10198229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inability of galactoside-specific mistletoe lectin to inhibit N-methyl-N-nitrosourea-induced tumor development in the urinary bladder of rats and to mediate a local cellular immune response after long-term administration.
    Kunze E; Schulz H; Gabius HJ
    J Cancer Res Clin Oncol; 1998; 124(2):73-87. PubMed ID: 9654190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulatory potency of the beta-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients.
    Hajto T; Hostanska K; Gabius HJ
    Cancer Res; 1989 Sep; 49(17):4803-8. PubMed ID: 2758413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial.
    Goebell PJ; Otto T; Suhr J; Rübben H
    J Urol; 2002 Jul; 168(1):72-5. PubMed ID: 12050495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in toxicity and antigenicity between mistletoe lectin I and viscotoxin A 3.
    Franz H; Kindt A; Eifler R; Ziska P; Benndorf R; Junghahn I
    Biomed Biochim Acta; 1983; 42(5):K21-5. PubMed ID: 6651797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The mistletoe myth--claims, reality and provable perspectives].
    Gabius HJ; André S; Kaltner H; Siebert HC; von der Lieth CW; Gabius S
    Z Arztl Fortbild (Jena); 1996 Apr; 90(2):103-10. PubMed ID: 8686332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Site-specific mutagenesis of mistletoe lectin: the role of RIP activity in apoptosis.
    Langer M; Möckel B; Eck J; Zinke H; Lentzen H
    Biochem Biophys Res Commun; 1999 Nov; 264(3):944-8. PubMed ID: 10544035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial.
    Semiglazov VF; Stepula VV; Dudov A; Schnitker J; Mengs U
    Anticancer Res; 2006; 26(2B):1519-29. PubMed ID: 16619567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulation of the maturation of dendritic cells in vitro by a fermented mistletoe extract.
    Stein GM; Büssing A; Schietzel M
    Anticancer Res; 2002; 22(6C):4215-9. PubMed ID: 12553059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mistletoe extracts standardized to mistletoe lectins in oncology: review on current status of preclinical research.
    Mengs U; Göthel D; Leng-Peschlow E
    Anticancer Res; 2002; 22(3):1399-407. PubMed ID: 12168816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The standardised mistletoe extract PS76A2 improves QoL in patients with breast cancer receiving adjuvant CMF chemotherapy: a randomised, placebo-controlled, double-blind, multicentre clinical trial.
    Semiglasov VF; Stepula VV; Dudov A; Lehmacher W; Mengs U
    Anticancer Res; 2004; 24(2C):1293-302. PubMed ID: 15154663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mistletoe lectin-1 increases tumor necrosis factor-alpha release in lipopolysaccharide-stimulated whole blood via inhibition of interleukin-10 production.
    Boneberg EM; Hartung T
    J Pharmacol Exp Ther; 2001 Sep; 298(3):996-1000. PubMed ID: 11504795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of mitochondrial Apo2.7 molecules and caspase-3 activation in human lymphocytes treated with the ribosome-inhibiting mistletoe lectins and the cell membrane permeabilizing viscotoxins.
    Büssing A; Vervecken W; Wagner M; Wagner B; Pfüller U; Schietzel M
    Cytometry; 1999 Oct; 37(2):133-9. PubMed ID: 10486525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of the cellular and humoral immune responses of tumor patients by mistletoe therapy.
    Stein G; Henn W; von Laue H; Berg P
    Eur J Med Res; 1998 Apr; 3(4):194-202. PubMed ID: 9533928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No evidence of stimulation of human tumor cell proliferation by a standardized aqueous mistletoe extract in vitro.
    Burger AM; Mengs U; Kelter G; Schüler JB; Fiebig HH
    Anticancer Res; 2003; 23(5A):3801-6. PubMed ID: 14666680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mistletoe or not mistletoe is still the question.
    Kiene H; Büschel G; Hornebar M
    Forsch Komplementarmed Klass Naturheilkd; 2001 Oct; 8(5):309-12. PubMed ID: 11760713
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficiency of treatment with galactoside-specific lectin from mistletoe against rat glioma.
    Lenartz D; Andermahr J; Plum G; Menzel J; Beuth J
    Anticancer Res; 1998; 18(2A):1011-4. PubMed ID: 9615756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic activity and absence of tumor growth stimulation of standardized mistletoe extracts in human tumor models in vitro.
    Kelter G; Schierholz JM; Fischer IU; Fiebig HH
    Anticancer Res; 2007; 27(1A):223-33. PubMed ID: 17352237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.